Join the Parkinson's Disease group to help and get support from people like you.
Parkinson's Disease News (Page 5)
Related terms: Parkinson's
FDA Medwatch Alert: Benztropine Mesylate Injection by Fresenius Kabi USA: Recall - Potential Presence Of Glass Particles
ISSUE: Fresenius Kabi USA is voluntarily recalling four lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the potential presence of glass particles...
FDA Medwatch Alert: Mirapex (pramipexole): Drug Safety Communication - Ongoing Safety Review, Possible Risk of Heart Failure
ISSUE: FDA notified healthcare profesionals about a possible increased risk of heart failure with Mirapex (pramipexole). Results of recent studies suggest a potential risk of heart failure that needs...
Higher Dose of Novartis Drug Exelon Patch Approved By FDA for Patients With Mild to Moderate Alzheimer's Disease
EAST HANOVER, N.J., Sept. 4, 2012 /PRNewswire/ – The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with...
Once-Daily Mirapex ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
RIDGEFIELD, Conn., March 23 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily Mirapex ER...
FDA Approves Once-Daily Mirapex ER for the Treatment of Early Parkinson's Disease
RIDGEFIELD, Conn., Feb. 22 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER (pramipexole...
FDA Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions
JERUSALEM--(BUSINESS WIRE)--Dec 14, 2009 - Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for...